A "crossomics" study analysing variability of different components in peripheral blood of healthy caucasoid individuals

Kristina Gruden, Matjaž Hren, Ana Herman, Andrej Blejec, Tanja Albrecht, Joachim Selbig, Chris Bauer, Johannes Schuchardt, Michal Or-Guil, Klemen Zupančič, Urban Svajger, Borut Stabuc, Alojz Ihan, Andreja Nataša Kopitar, Maja Ravnikar, Miomir Knežević, Primož Rožman, Matjaž Jeras, Kristina Gruden, Matjaž Hren, Ana Herman, Andrej Blejec, Tanja Albrecht, Joachim Selbig, Chris Bauer, Johannes Schuchardt, Michal Or-Guil, Klemen Zupančič, Urban Svajger, Borut Stabuc, Alojz Ihan, Andreja Nataša Kopitar, Maja Ravnikar, Miomir Knežević, Primož Rožman, Matjaž Jeras

Abstract

Background: Different immunotherapy approaches for the treatment of cancer and autoimmune diseases are being developed and tested in clinical studies worldwide. Their resulting complex experimental data should be properly evaluated, therefore reliable normal healthy control baseline values are indispensable.

Methodology/principal findings: To assess intra- and inter-individual variability of various biomarkers, peripheral blood of 16 age and gender equilibrated healthy volunteers was sampled on 3 different days within a period of one month. Complex "crossomics" analyses of plasma metabolite profiles, antibody concentrations and lymphocyte subset counts as well as whole genome expression profiling in CD4+T and NK cells were performed. Some of the observed age, gender and BMI dependences are in agreement with the existing knowledge, like negative correlation between sex hormone levels and age or BMI related increase in lipids and soluble sugars. Thus we can assume that the distribution of all 39.743 analysed markers is well representing the normal Caucasoid population. All lymphocyte subsets, 20% of metabolites and less than 10% of genes, were identified as highly variable in our dataset.

Conclusions/significance: Our study shows that the intra-individual variability was at least two-fold lower compared to the inter-individual one at all investigated levels, showing the importance of personalised medicine approach from yet another perspective.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Overview of the experimental design.
Figure 1. Overview of the experimental design.
Sixteen gender and age matched healthy individuals were enrolled in a study. Fasting morning blood samples were taken on three days within one month and analysed using different omics approaches. Fasting morning samples were collected from 16 volunteer three times within a one month period.
Figure 2. Overview of metabolite profiles variability…
Figure 2. Overview of metabolite profiles variability found in plasma samples of healthy volunteers by principle component analysis score plot.
Triangle – male volunteer, circle – female volunteer, coloured according to volunteers, labels shows sampling number within one volunteer. PC - principal component.
Figure 3. Average concentrations of two soluble…
Figure 3. Average concentrations of two soluble sugars, glucose and mannose, are significantly increased in plasma samples of healthy volunteers with higher BMI values.
pGlucose = 0.0014, pmannose = 0.0001. Error bars represent standard error within monthly measurements.
Figure 4. Variability of different lymphocyte subsets…
Figure 4. Variability of different lymphocyte subsets cell counts and antibody concentrations assessed in blood samples of healthy individuals.
The HCA was performed both, for the analysis of samples and the variation of each parameter. The colour scale denotes increasing cell counts/concentrations of the measured parameters, with both extremes being low (blue) and high (yellow). The total numbers of leukocytes (WBC), lymphocytes (LYM), natural killer cells (NK), CD8+ and CD4+ T lymphocytes and their activated forms (aNK, aCD8+ T, aCD4+ T), were determined by flow cytometry. The concentrations of IgG and IgM antibodies are also included. Samples are marked by consecutive number of volunteer (P1–P17), volunteer gender (F, M) and sampling day (D1–5).
Figure 5. Intra-individual variability in gene expression…
Figure 5. Intra-individual variability in gene expression compared to inter-individual variability.
Variabilities are represented as boxplots of gene expression CV for each individual and in complete dataset. A) CD4+ T and B) NK cells. For subject P9 this evaluation was not possible for CD4+ T cell dataset as only one sample out of the three passed the technical quality control in all steps of the procedure. The same was true for subjects P9, P13 and P12 in NK cells dataset.
Figure 6. The pattern of transcripts with…
Figure 6. The pattern of transcripts with variable day-to-day expression seems to be in majority individuum-specific.
Distribution of transcripts with high day to day variability in expression among healthy individuals for A) CD4+ T, and B) NK cells is shown. Transcripts identified as highly variable (CV>0.5) in at least one individual are ordered in rows of the heat map (1952 transcripts for CD4+ T and 2635 transcripts for NK cells). Individuals included in our study are listed in columns. Grey colour – the transcript was not identified as highly variable in the particular volunteer. Black colour – the transcript was identified as highly variable in particular volunteer.
Figure 7. The most prominent BMI-related changes…
Figure 7. The most prominent BMI-related changes in gene expression were found for interleukin 7 receptor (IL7R), insulin-like growth factor binding protein 3 (IGFBP3), defensin 3 (DEFA3) and DO beta major histocompatibility complex, class II (HLA-DOB).
CD4+ T cells - open squares, NK cells - closed circles. Error bars represent intra-individual standard error.

References

    1. Cai MY, Hou JH, Rao HL, Luo RZ, Li M, et al. High expression of H3K27me3 in human hepatocellular carcinomas correlates closely with vascular invasion and predicts worse prognosis in patients. Mol Med. 2011;17:12–20.
    1. Takahashi S, Miura N, Harada T, Wang Z, Wang X, et al. Prognostic impact of clinical course-specific mRNA expression profiles in the serum of perioperative patients with esophageal cancer in the ICU: a case control study. J Transl Med. 2010;8:103.
    1. Andersson U, Lindberg J, Wang S, Balasubramanian R, Marcusson-Stahl M, et al. A systems biology approach to understanding elevated serum alanine transaminase levels in a clinical trial with ximelagatran. Biomarkers. 2009;14:572–586.
    1. Whitney AR, Diehn M, Popper SJ, Alizadeh AA, Boldrick JC, et al. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci U S A. 2003;100:1896–1901.
    1. Cobb JP, Mindrinos MN, Miller-Graziano C, Calvano SE, Baker HV, et al. Application of genome-wide expression analysis to human health and disease. Proc Natl Acad Sci U S A. 2005;102:4801–4806.
    1. Radich JP, Mao M, Stepaniants S, Biery M, Castle J, et al. Individual-specific variation of gene expression in peripheral blood leukocytes. Genomics. 2004;83:980–988.
    1. Eady JJ, Wortley GM, Wormstone YM, Hughes JC, Astley SB, et al. Variation in gene expression profiles of peripheral blood mononuclear cells from healthy volunteers. Physiol Genomics. 2005;22:402–411.
    1. Xu T, Shu CT, Purdom E, Dang D, Ilsley D, et al. Microarray analysis reveals differences in gene expression of circulating CD8(+) T cells in melanoma patients and healthy donors. Cancer Res. 2004;64:3661–3667.
    1. Le Dieu R, Taussig DC, Ramsay AG, Mitter R, Miraki-Moud F, et al. Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts. Blood. 2009;114:3909–3916.
    1. Critchley-Thorne RJ, Yan N, Nacu S, Weber J, Holmes SP, et al. Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma. PLoS Med. 2007;4:e176.
    1. Palmer C, Diehn M, Alizadeh AA, Brown PO. Cell-type specific gene expression profiles of leukocytes in human peripheral blood. BMC Genomics. 2006;7:115.
    1. Tanner MA, Berk LS, Felten DL, Blidy AD, Bit SL, et al. Substantial changes in gene expression level due to the storage temperature and storage duration of human whole blood. Clin Lab Haematol. 2002;24:337–341.
    1. Debey S, Schoenbeck U, Hellmich M, Gathof BS, Pillai R, et al. Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types. Pharmacogenomics J. 2004;4:193–207.
    1. Hartel C, Bein G, Muller-Steinhardt M, Kluter H. Ex vivo induction of cytokine mRNA expression in human blood samples. J Immunol Methods. 2001;249:63–71.
    1. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Moser K, et al. Expression levels for many genes in human peripheral blood cells are highly sensitive to ex vivo incubation. Genes Immun. 2004;5:347–353.
    1. Atzori L, Antonucci R, Barberini L, Griffin JL, Fanos V. Metabolomics: a new tool for the neonatologist. J Matern Fetal Neonatal Med. 2009;22(Suppl 3):50–53.
    1. Gwinner W. Renal transplant rejection markers. World J Urol. 2007;25:445–455.
    1. Ritchie SA, Ahiahonu PW, Jayasinghe D, Heath D, Liu J, et al. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection. BMC Med. 2010;8:13.
    1. MacIntyre DA, Jimenez B, Lewintre EJ, Martin CR, Schafer H, et al. Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups. Leukemia. 2010;24:788–797.
    1. Yu Z, Kastenmuller G, He Y, Belcredi P, Moller G, et al. Differences between Human Plasma and Serum Metabolite Profiles. PLoS One. 2011;6:e21230.
    1. Huzarewich RL, Siemens CG, Booth SA. Application of “omics” to prion biomarker discovery. J Biomed Biotechnol. 2010;2010:613504.
    1. McCombe PA, Greer JM, Mackay IR. Sexual dimorphism in autoimmune disease. Curr Mol Med. 2009;9:1058–1079.
    1. Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol. 2004;5:133–139.
    1. Dorshkind K, Swain S. Age-associated declines in immune system development and function: causes, consequences, and reversal. Curr Opin Immunol. 2009;21:404–407.
    1. Yan J, Greer JM, Hull R, O'Sullivan JD, Henderson RD, et al. The effect of ageing on human lymphocyte subsets: comparison of males and females. Immun Ageing. 2010;7:4.
    1. Marti A, Marcos A, Martinez JA. Obesity and immune function relationships. Obes Rev. 2001;2:131–140.
    1. 2005. (2005) R: A language and environment for statistical computing.
    1. Hren M, Nikolic P, Rotter A, Blejec A, Terrier N, et al. ‘Bois noir’ phytoplasma induces significant reprogramming of the leaf transcriptome in the field grown grapevine. BMC Genomics. 2009;10:460.
    1. Saeed AI, Sharov V, White J, Li J, Liang W, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques. 2003;34:374–378.
    1. Schuchhardt J, Glintschert A, Hartl D, Irmler M, Beckers J, et al. BrainProfileDB - a platform for integration of functional genomics data. Proteomics. 2008;8:1162–1164.
    1. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B (Methodological) 1995;57:289–300.
    1. Duvigneau JC, Hartl RT, Teinfalt M, Gemeiner M. Delay in processing porcine whole blood affects cytokine expression. J Immunol Methods. 2003;272:11–21.
    1. Brandacher G, Hoeller E, Fuchs D, Weiss HG. Chronic immune activation underlies morbid obesity: is IDO a key player? Curr Drug Metab. 2007;8:289–295.
    1. Marcos A, Nova E, Montero A. Changes in the immune system are conditioned by nutrition. Eur J Clin Nutr. 2003;57(Suppl 1):S66–69.
    1. Manco M, Fernandez-Real JM, Equitani F, Vendrell J, Valera Mora ME, et al. Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women. J Clin Endocrinol Metab. 2007;92:483–490.
    1. Michaud A, Dardari R, Charrier E, Cordeiro P, Herblot S, et al. IL-7 enhances survival of human CD56bright NK cells. J Immunother. 2010;33:382–390.
    1. Liu X, Leung S, Wang C, Tan Z, Wang J, et al. Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease. Nat Med. 2010;16:191–197.
    1. Nady S, Ignatz-Hoover J, Shata MT. Interleukin-12 is the optimum cytokine to expand human Th17 cells in vitro. Clin Vaccine Immunol. 2009;16:798–805.
    1. Cotterill L, Payne D, Levinson S, McLaughlin J, Wesley E, et al. Replication and meta-analysis of 13,000 cases defines the risk for interleukin-23 receptor and autophagy-related 16-like 1 variants in Crohn's disease. Can J Gastroenterol. 2010;24:297–302.
    1. Douek DC, Altmann DM. HLA-DO is an intracellular class II molecule with distinctive thymic expression. Int Immunol. 1997;9:355–364.
    1. Ferraro R, Lillioja S, Fontvieille AM, Rising R, Bogardus C, et al. Lower sedentary metabolic rate in women compared with men. J Clin Invest. 1992;90:780–784.
    1. Geppert J, Min Y, Neville M, Lowy C, Ghebremeskel K. Gender-specific fatty acid profiles in platelet phosphatidyl-choline and -ethanolamine. Prostaglandins Leukot Essent Fatty Acids. 2010;82:51–56.
    1. Saadatian-Elahi M, Slimani N, Chajes V, Jenab M, Goudable J, et al. Plasma phospholipid fatty acid profiles and their association with food intakes: results from a cross-sectional study within the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr. 2009;89:331–346.
    1. Trautwein EA, Hayes KC. Taurine concentrations in plasma and whole blood in humans: estimation of error from intra- and interindividual variation and sampling technique. Am J Clin Nutr. 1990;52:758–764.
    1. de Groot RH, van Boxtel MP, Schiepers OJ, Hornstra G, Jolles J. Age dependence of plasma phospholipid fatty acid levels: potential role of linoleic acid in the age-associated increase in docosahexaenoic acid and eicosapentaenoic acid concentrations. Br J Nutr. 2009;102:1058–1064.
    1. DelaRosa O, Pawelec G, Peralbo E, Wikby A, Mariani E, et al. Immunological biomarkers of ageing in man: changes in both innate and adaptive immunity are associated with health and longevity. Biogerontology. 2006;7:471–481.

Source: PubMed

3
Se inscrever